Literature DB >> 15333499

Guidelines for computer modeling of diabetes and its complications.

.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15333499     DOI： 10.2337/diacare.27.9.2262

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  79 in total

1.  Simulating the real world of antihyperglycaemic therapies in type 2 diabetes.

Authors:  Amanda I Adler
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes.

Authors:  Andrew J Palmer; Craig J Currie
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes.

Authors:  David C Kendrick; Davis Bu; Eric Pan; Blackford Middleton
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

Review 4.  Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors:  Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal:  Am Health Drug Benefits       Date:  2014-05

Review 5.  Mechanistic systems modeling to guide drug discovery and development.

Authors:  Brian J Schmidt; Jason A Papin; Cynthia J Musante
Journal:  Drug Discov Today       Date:  2012-09-19       Impact factor: 7.851

Review 6.  Dynamic microsimulation models for health outcomes: a review.

Authors:  Carolyn M Rutter; Alan M Zaslavsky; Eric J Feuer
Journal:  Med Decis Making       Date:  2010-05-18       Impact factor: 2.583

7.  Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data.

Authors:  Ulf-G Gerdtham; Philip Clarke; Alison Hayes; Soffia Gudbjornsdottir
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Authors:  Tom W C Lung; Philip M Clarke; Alison J Hayes; Richard J Stevens; Andrew Farmer
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

Review 9.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.

Authors:  Rui Li; Ping Zhang; Lawrence E Barker; Thomas J Hoerger
Journal:  Diabetes Care       Date:  2010-03-23       Impact factor: 17.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.